Fast Track Designation is a process designed to expedite the development and review of drugs that are intended to treat serious conditions and fill an unmet medical need. This designation aims to bring promising therapies to patients more quickly. The U.S. Food and Drug Administration (FDA) grants Fast Track status to facilitate the development and expedite the review of drugs, including those for cancer.
